Table 2. Genetic alterations in the current cases.

BRAFV600E	43 (63.2%)*
HRAS	0
KRAS	0
NRAS	0
RET/PTC1	6 (8.8%)
RET/PTC3	1 (1.5%)
ETV6(ex4)/NTRK3	4 (5.9%)
ETV6(ex5)/NTRK3	0
AKAP9/BRAF	0
TERT C250T	0
TERT C228T	0

^*including 4 cases in which the strength of A signal in the sequence chromatogram was less than 20% compared to that of T signal.